Prognosis

J&J Shot Reaffirmed in U.S.; Apple Spurs Employees: Virus Update

Inside a Pfizer Vaccine Production Facility
Lock
This article is for subscribers only.

U.S. vaccine advisers reaffirmed support for Johnson & Johnson’s Covid-19 vaccine after reviewing reports of rare blood clots that prompted a 10-day pause for the shot. Regulators could decide to resume use of the vaccine as soon as Friday evening.

Apple Inc. is working up a program to get employees vaccinated. New York City opened all of its vaccination sites to walk-ins and Governor Andrew Cuomo said the state will help get shots to the city’s grocery-store workers and delivery drivers.